Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2025-12-24 @ 2:49 PM
NCT ID:
NCT01416259
Eligibility Criteria:
Inclusion Criteria:
* Subjects in good health
* aged between 18-50 years
* weigh at least 50 kg (110 pounds)
* have a body mass index of 18-32 kg/m2 inclusive
* capable of understanding and complying with the protocol
* have signed the informed consent
Exclusion Criteria:
* have a history of drug abuse or are current smokers
* have a known hypersensitivity to Moxifloxacin or granisetron
* a history or presence of clinically significant abnormal 12-lead ECG or an ECG with QTc by Bazett's correction of \> 450 ms in men, \> 470 ms in women on the screening ECG
* PR \> 240 ms, QRS \> 110 ms or a history of prolongation of QT interval
* a family history of Long QT Syndrome or cardiac disease
* may not have used any medications or consumed any foods contraindicated in the protocol
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT01416259
Study Brief:
Protocol Section:
NCT01416259